Skip to main content
Top
Published in: Acta Diabetologica 5/2024

29-02-2024 | Short Communication

Double mutation in genes associated to FH and diabetes

Authors: Susanna Longo, Francesca Cassandra, Iris Cardolini, Martina Montagna, Alessandro Nucera, Massimo Federici

Published in: Acta Diabetologica | Issue 5/2024

Login to get access

Excerpt

Familial hypercholesterolemia (FH) is an autosomal codominant hereditary disease with complete penetrance. The prevalence of heterozygous FH (HeFH) ranges 1:250–500 people in most countries; while, the prevalence of homozygous FH (HoFH) is estimated around 1:200.000–300.000 but is often underdiagnosed [1]. …
Literature
Metadata
Title
Double mutation in genes associated to FH and diabetes
Authors
Susanna Longo
Francesca Cassandra
Iris Cardolini
Martina Montagna
Alessandro Nucera
Massimo Federici
Publication date
29-02-2024
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 5/2024
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-024-02235-y

Other articles of this Issue 5/2024

Acta Diabetologica 5/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine